Closing date: close of business Monday, 19 November 2018
Strategic Communications Branch, Queensland Department of Health
Queensland Health would like to speak to consumers to understand how, when and where they look for health information, including everything from symptoms and condition information through to how to find a specialist to book an appointment.
Role of the Consumer
Consumers taking part in these interviews will contribute to the understanding of how health information is accessed in Queensland both now and how they would like this to improve in the future. They will also raise key consumer and community perspectives from their personal experience, including considerations such as the barriers to accessing healthcare that may be cultural, financial or emotional. Consumers bring their lived experience and those of people in their networks to these discussions.
Who is this for?
Expressions of interest are invited from consumers who have looked up healthcare information online at any time in the last few months.
Time and Location
A series of one-on-one interviews lasting approximately 30 minutes will be held, either in-person in South Brisbane, or via video conference or phone call.
Remuneration and Support
Consumers who participate will receive a $20 gift card for their time.
How to apply
Please complete this Expression of Interest and return to Health Consumers Queensland via email to: [email protected]. For assistance completing this Expression of Interest, please contact Michael Taylor via [email protected] or by phone on 07 3012 9090.
Closing date: close of business Wednesday, 26 September 2018
Department of Health, System Planning Branch
The Department of Health’s System Planning Branch is seeking two consumer representatives to join the Advancing Kidney Care 2026 Collaborative (the Collaborative). The Collaborative would greatly benefit through the participation of an Aboriginal and Torres Strait Islander consumer representative.
About System Planning Branch
System Planning Branch is responsible for leading health service planning activities of statewide significance with a medium to long term horizon. This role entails:
- Identifying the comparative health service needs of localities, populations and patient cohorts (both current and over the anticipated medium to long term future) to inform the statewide allocation of resources to achieve service access equity
- Facilitating integration of planning at the system level to align service enablers with future need e.g. workforce, infrastructure, funding
- Facilitating vertical integration of planning for health services between the Department of Health (DOH) and Hospital and Health Services (HHS) through identification of high level service directions and service outcomes, to act as a point of alignment for health service planning and investment by the DOH, HHS and service partners from the private and not-for-profit sectors
- Supporting other departmental and HHS level planning processes through provision of technical expertise in health service planning content and process, including technical analysis on projected service need.
The Advanced Kidney Care 2026 Collaborative Committee will be responsible for implementing the strategic actions arising from recently completed statewide planning for renal health and renal health services. Members are being appointed to 30 June 2019.
The specific aims of the Collaborative include (to be ratified by members)
- Implement the strategic directions and priority actions in Advancing Kidney Care 2026.
- Develop a workplan and review progress against the workplan at each meeting.
- Advocate for timely access to quality renal care with the Minister for Health and Ambulance and Boards and Executive of HHS, aligned with consumer views of what matters.
- Ensure that initiatives and decisions to be implemented within HHSs are sensitive to the local context based on recommendations from sub-Collaboratives and/or structured engagement that includes representation from the executive and clinical leadership (multidisciplinary) within each HHS.
- Champion initiatives that promote the effective and optimal use of available resources.
Closing date: Friday 5 October 2018
Allied Health Professions Office
Getting consumers involved in a ten year strategy for allied health professionals in Queensland
Allied health professionals play a valuable role in delivering effective healthcare for Queenslanders.
The next 10 years will present unique challenges and changes for the delivery of healthcare. As integral members of the healthcare team, allied health professionals can play a key role in facing the challenges ahead. The draft Queensland Allied Health: A 10 year Strategy (2018 -2028) maps a clear direction for improved utilisation of the allied health workforce to assist in meeting the challenges ahead.
To provide input into the Queensland Allied Health: 10 year Strategy (2018-2028).
Role of the Consumer
At these focus groups you’ll be a part of a conversation led by Health Consumers Queensland to hear your thoughts and ideas about allied health.
Who is this for?
Whilst it’s desirable for the successful candidates to have used Allied Health services in Queensland, this is not mandatory.
Time and Location
Rural and Remote Consumers
Date: Tuesday 9 October 2018
Time: 9.30am – 11.00am
Location: via Teleconference
Brisbane based Consumers
Date: Tuesday 16 October 2018
Time: 9.30am – 11.00am
Location: Health Consumers Queensland (new office) Adelaide St, Brisbane
Remuneration and Support
$60 gift card supplied to those who attend the group either in person or via teleconference.
How to apply
Please complete this Expression of Interest and return to Health Consumers Queensland via [email protected] For assistance completing this Expression of Interest, please contact Michael Taylor via [email protected] or by phone on 07 3012 9090.
Closing date: close of business Friday, 12 October 2018
As part of the Youth Mental Health Program being progressed by Queensland Health, the Mental Health Alcohol and Other Drugs (MHAOD) Branch has engaged the Queensland Centre for Mental Health Research (QCMHR) to develop an Evaluation Framework for the new adolescent extended treatment facility due to commence operation in 2020..
Expression of Interest Details
This Expression of Interest (EOI) is seeking members for an Advisory Group to be chaired by the QCMHR. The QCMHR project team is seeking to engage key stakeholders as part of consultations to ensure relevance and appropriateness of the evaluation framework from both technical and service user perspectives.
The Adolescent Extended Treatment (AET) Facility Evaluation Framework Advisory Group (Advisory Group) will provide advice and feedback on the indicative framework prior to endorsement being sought from the Executive Director, MHAODB ahead of implementation prior to the opening of the new facility. The project’s progress will be reported through the Youth Mental Health Oversight Committee established to oversee the Youth Mental Health Program.
The Department of Health in collaboration with consumers and carers, Department of Education, Health Consumers Queensland and other key stakeholders led the successful implementation of the Government response for the six recommendations of the Barrett Adolescent Centre (BAC) Commission of Inquiry (COI) Report to 30 June 2017. See the youth mental health website for further information
As part of delivering the Government response to recommendation 3, the QCMHR was engaged to identify existing clinical and program evaluation frameworks for extended treatment for adolescents and young people with severe, persistent and complex mental health issues. A copy of the QCMHR report can be viewed here.
Adolescent extended treatment (AET) facility
The Queensland Government committed more than $68M for capital works to rebuild and expand mental healthcare services for young people as part of the State Budget announcement on 13 June 2017.
This includes delivery of a new adolescent extended treatment (AET) facility to be built on The Prince Charles Hospital (TPCH) campus in Brisbane. The facility will operationalize a new state-wide AET Model of Service (MOS) extending the continuum of mental health service options available to adolescents experiencing severe and complex mental health issues and their families/carers. The facility will provide integrated mental health and educational/vocational inpatient treatment (12 beds) and rehabilitation for an extended period (target length of stay up to 6 months) for young people across Queensland aged 13 to 18 experiencing severe and complex mental health issues with the least possible disruption to their family, educational, social and community connections.
Children’s Health Queensland Hospital and Health Service (CHQ HHS) is leading the commissioning of this facility as part of the Youth Mental Health Program.
Closing date: close of business midnight AEST on Sunday 23 September 2018
Consumers Health Forum of Australia
The Dental Benefits Act 2008 (the Act) is the mechanism under which the Australian Government pays benefits for dental services to eligible dental patients. The Act provides a legal framework for the Child Dental Benefit Schedule. Section 68 stipulates that the Minister for Health must cause an independent review of the operation of the Act to be undertaken as soon as possible after the first anniversary of the commencement of the Act; and further independent reviews as soon as practicable after the Act’s third anniversary and at three yearly intervals thereafter. Section 68 of the Act requires the Consumers Health Forum of Australia (CHF) to nominate a consumer representative to participate In the Review Committee.
The Review Committee comprises of the following persons:
- person occupying the position of Commonwealth Chief Medical Officer;
- a person nominated by the Australian Dental Association;
- a person nominated by the Consumers’ Health Forum of Australia; and
- two other persons nominated by the Minister, at least one of whom must have qualifications in medicine or dentistry.
The Review Committee will undertake the fourth independent review of the Dental Benefits Act 2008 (the Act) and will assess the practical operation of the Act in regard to access and delivery of services, including an assessment of:
- eligibility notification and confirmation processes;
- claiming processes; and
- the Informed Financial Consent regime.
The Review Committee may also consider opportunities to improve the operation and administration of the Child Dental Benefits Schedule to allow for the most efficient, effective and sustainable delivery of dental benefits and services.
Role of the Consumer
The work of the Review Committee will consist of meetings in Canberra plus out of session work as necessary from October 2018, with the report provided to the Minister of Health In early 2019. Meeting dates have yet to be confirmed. Please note that travel costs and sitting fees will be covered by the Department of Health for this work.
How to apply
CHF invites expressions of interest from consumer representatives by midnight AEST on Sunday 23 September 2018. The details of two consumer representatives will be forwarded to the Minister of Health for possible appointment. Interested consumer representatives will need to:
- Complete a CHF nomination form available online at https://chf.org.au/representation/forms/consumer-representative-nomination-form
- Attach a letter of endorsement from a supporting health consumer organisation and/or provide sound demonstration of your links with a consumer base. This information ensures that consumer representatives are accountable to consumers. Please note that the health consumer group need not be a CHF member. This process ensures consumer representatives are placed with the confidence of consumers and have in place a consultative base enabling reps to draw from and report to consumers.
- Attach a short CV in pdf format to be forwarded to the Department of Health
Please contact Ghislaine Martin on 02 6273 5444 or via email at [email protected] should you have any queries.
Friday, 16 November 2018
Ordinary people can make a difference to the health of their community. Could that person be you?
TAKE YOUR FIRST STEPS TOWARDS MAKING A DIFFERENCE IN HEALTH CARE
Many people do not know that they can influence the health care system. Come along to learn how you can use your experience of health care to create change.
- How the health system works
- What is a health consumer?
- How do health consumers influence healthcare?
- What experiences of healthcare do you have?
- Tips for being a strong voice
- Ways to become involved and make change
- What you can do next
This session will be a friendly, casual and supportive way to explore whether you would like to become involved.
Closing date: COB (AEST) Monday, 3 September 2018
The Australian Government recently announced that Painaustralia will be supported to develop a National Strategic Action Plan on Pain Management (the Action Plan).
The Action Plan is a critical step towards improving quality of life for millions of Australians that live with chronic pain (daily pain that lasts three months or longer) and reducing the burden of pain which is increasingly impacting families, communities and the economy. The Action Plan will set out key priority areas and measures to improve access to, and knowledge of best practice pain management, in the next three years.
The Action Plan will build on the 2010 National Pain Strategy which was endorsed by 200 stakeholders including those working in pain medicine, allied health, drug and addiction medicine, mental health, rural health, general practice, pharmacy as well as consumers and carers. The Strategy provides a blueprint for the treatment of pain, recommending an interdisciplinary approach to deliver best practice pain management. It identifies 6 key goals to reduce the pain burden.
Eight years on, these goals remain relevant and will inform the new National Action Plan, while new priorities may have emerged that need to be considered.
The voice of consumers is critically important in shaping a consumer centered Actional Plan. As part of a wide consultation strategy, Painaustralia has funded the Consumers Health Forum of Australia to host a Consumer Pain Roundtable to hear your views about the priorities that you think will make the most difference, whether you are living with chronic pain, caring for someone with chronic pain, working in the health sector or simply have an interest in addressing this national health challenge.
The Department of Health is seeking consumer representation for eight Prostheses Clinical Advisory Groups.
The Prostheses List Advisory Committee (PLAC) advises the Minister on the suitability to list on the Prostheses List under the Private Health Insurance Act 2007. The Prostheses List Clinical Advisory Groups (CAGs) are expert sub-committees of the Prostheses List Advisory Committee (PLAC) providing advice on issues relating to the clinical effectiveness of prostheses, including effectiveness compared to other devices. The PLAC makes recommendations to the Minister on which products are listed on the Prostheses List. Listing on the Prostheses List affects whether or not a prostheses benefit is available to consumers from a private health insurer.
Nominations/renominations are now due for the following Clinical Advisory Groups:
- Prostheses Clinical Advisory Group – Specialist Orthopaedic
- Prostheses Clinical Advisory Group – Cardiac
- Prostheses Clinical Advisory Group – Cardiothoracic
- Prostheses Clinical Advisory Group – Ophthalmic
- Prostheses Clinical Advisory Group – Orthopaedic (Hips)
- Prostheses Clinical Advisory Group – Orthopaedic (Knees – KPCAG)
- Prostheses Clinical Advisory Group – Spinal
- Prostheses Clinical Advisory Group – Vascular Stents and Grafts
The CAGs refer applications to the Medical Services Advisory Committee (MSAC) where the:
- New medical device employs a medical service that is not currently covered in the Medicare Benefits Schedule (MBS), or
- New medical device might be used in a medical service that is currently described in the MBS, but potentially extends the range of indications/patients beyond the original intent of the MBS item/s.
The CAGs also advise the PLAC on:
- The evidence and information they require to assess applications to list medical devices on the Prostheses List.
- Any concerns in relation to safety and/or performance of medical devices, for referral to the Therapeutic Goods Administration.
- Reviewing the listing of medical devices in view of issues relating to comparative health outcomes.
- On any other matter, as required.